On Tuesday, Horizon confirmed it is in “highly preliminary” discussions with Amgen, Johnson & Johnson and Sanofi about a potential takeover. The company cautioned no offer may be forthcoming and an acquisition might not materialize. The Wall Street Journal first reported on the discussions.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,